BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

563 related articles for article (PubMed ID: 31097406)

  • 21. Regulation of the follistatin gene by RSPO-LGR4 signaling via activation of the WNT/β-catenin pathway in skeletal myogenesis.
    Han XH; Jin YR; Tan L; Kosciuk T; Lee JS; Yoon JK
    Mol Cell Biol; 2014 Feb; 34(4):752-64. PubMed ID: 24344199
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression and functional regulation of stemness gene Lgr5 in esophageal squamous cell carcinoma.
    Lv Z; Yu JJ; Zhang WJ; Xiong L; Wang F; Li LF; Zhou XL; Gao XY; Ding XF; Han L; Cai YF; Ma W; Wang LX
    Oncotarget; 2017 Apr; 8(16):26492-26504. PubMed ID: 28404917
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [hsa_circ_0000231 affects the progression of tongue squamous cell carcinoma by activating Wnt/β-catenin signaling pathway].
    Chen QW; Wang DQ; Ding BX; Tang MM; Li XG; Zhou JY; Xu K; Fang ZR; Han L; Wu H
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2022 Oct; 57(10):1230-1239. PubMed ID: 36319130
    [No Abstract]   [Full Text] [Related]  

  • 24. Akt/Ezrin Tyr353/NF-κB pathway regulates EGF-induced EMT and metastasis in tongue squamous cell carcinoma.
    Wang Y; Lin Z; Sun L; Fan S; Huang Z; Zhang D; Yang Z; Li J; Chen W
    Br J Cancer; 2014 Feb; 110(3):695-705. PubMed ID: 24346284
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mena as a key enhancer factor of EMT to promote metastasis of human tongue squamous cell carcinoma.
    Cui H; Liang X; Zhu Y; Elayah SA; Qi H; Xie L; Guo Z; Siya F; Ming Y; Yuxin G; Tu J; Na S
    Oral Dis; 2024 May; 30(4):2084-2096. PubMed ID: 37203597
    [TBL] [Abstract][Full Text] [Related]  

  • 26. FGF1-FGFR1 axis promotes tongue squamous cell carcinoma (TSCC) metastasis through epithelial-mesenchymal transition (EMT).
    Jiao J; Zhao X; Liang Y; Tang D; Pan C
    Biochem Biophys Res Commun; 2015 Oct; 466(3):327-32. PubMed ID: 26362179
    [TBL] [Abstract][Full Text] [Related]  

  • 27. RSPO2 suppresses colorectal cancer metastasis by counteracting the Wnt5a/Fzd7-driven noncanonical Wnt pathway.
    Dong X; Liao W; Zhang L; Tu X; Hu J; Chen T; Dai X; Xiong Y; Liang W; Ding C; Liu R; Dai J; Wang O; Lu L; Lu X
    Cancer Lett; 2017 Aug; 402():153-165. PubMed ID: 28600110
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of R-spondin 2 in arterial lymphangiogenesis and atherosclerosis.
    Singla B; Lin HP; Chen A; Ahn W; Ghoshal P; Cherian-Shaw M; White J; Stansfield BK; Csányi G
    Cardiovasc Res; 2021 May; 117(6):1489-1509. PubMed ID: 32750106
    [TBL] [Abstract][Full Text] [Related]  

  • 29. R-spondin signalling is essential for the maintenance and differentiation of mouse nephron progenitors.
    Vidal VP; Jian-Motamedi F; Rekima S; Gregoire EP; Szenker-Ravi E; Leushacke M; Reversade B; Chaboissier MC; Schedl A
    Elife; 2020 May; 9():. PubMed ID: 32324134
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hexokinase 2 enhances the metastatic potential of tongue squamous cell carcinoma via the SOD2-H2O2 pathway.
    Wang W; Liu Z; Zhao L; Sun J; He Q; Yan W; Lu Z; Wang A
    Oncotarget; 2017 Jan; 8(2):3344-3354. PubMed ID: 27926482
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long non-coding RNA NKILA inhibits migration and invasion of tongue squamous cell carcinoma cells via suppressing epithelial-mesenchymal transition.
    Huang W; Cui X; Chen J; Feng Y; Song E; Li J; Liu Y
    Oncotarget; 2016 Sep; 7(38):62520-62532. PubMed ID: 27613832
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reconstitution of R-spondin:LGR4:ZNRF3 adult stem cell growth factor signaling complexes with recombinant proteins produced in Escherichia coli.
    Moad HE; Pioszak AA
    Biochemistry; 2013 Oct; 52(41):7295-304. PubMed ID: 24050775
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Overexpression of HMGA2 promotes tongue cancer metastasis through EMT pathway.
    Zhao XP; Zhang H; Jiao JY; Tang DX; Wu YL; Pan CB
    J Transl Med; 2016 Jan; 14():26. PubMed ID: 26818837
    [TBL] [Abstract][Full Text] [Related]  

  • 34. FSCN1 is an effective marker of poor prognosis and a potential therapeutic target in human tongue squamous cell carcinoma.
    Chen Y; Tian T; Li ZY; Wang CY; Deng R; Deng WY; Yang AK; Chen YF; Li H
    Cell Death Dis; 2019 May; 10(5):356. PubMed ID: 31043585
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MiR-940 inhibits migration and invasion of tongue squamous cell carcinoma via regulatingCXCR2/NF-κB system-mediated epithelial-mesenchymal transition.
    Ma T; Zhao Z; Wang Z; Wang C; Zhang L
    Naunyn Schmiedebergs Arch Pharmacol; 2019 Nov; 392(11):1359-1369. PubMed ID: 31214736
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of LGR4/EGFR signaling on cell growth and cancer stem cell-like characteristics in liver cancer.
    Liu Y; Zhang Y; Chen S; Zhong X; Liu Q
    Cytokine; 2023 May; 165():156185. PubMed ID: 37001327
    [TBL] [Abstract][Full Text] [Related]  

  • 37. RSPO2 and RANKL signal through LGR4 to regulate osteoclastic premetastatic niche formation and bone metastasis.
    Yue Z; Niu X; Yuan Z; Qin Q; Jiang W; He L; Gao J; Ding Y; Liu Y; Xu Z; Li Z; Yang Z; Li R; Xue X; Gao Y; Yue F; Zhang XH; Hu G; Wang Y; Li Y; Chen G; Siwko S; Gartland A; Wang N; Xiao J; Liu M; Luo J
    J Clin Invest; 2022 Jan; 132(2):. PubMed ID: 34847079
    [TBL] [Abstract][Full Text] [Related]  

  • 38. TRAF4 enhances oral squamous cell carcinoma cell growth, invasion and migration by Wnt-β-catenin signaling pathway.
    Yang J; Wei D; Wang W; Shen B; Xu S; Cao Y
    Int J Clin Exp Pathol; 2015; 8(9):11837-46. PubMed ID: 26617938
    [TBL] [Abstract][Full Text] [Related]  

  • 39. RSPO-LGR4 functions via IQGAP1 to potentiate Wnt signaling.
    Carmon KS; Gong X; Yi J; Thomas A; Liu Q
    Proc Natl Acad Sci U S A; 2014 Apr; 111(13):E1221-9. PubMed ID: 24639526
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Xenotropic and polytropic retrovirus receptor 1 (XPR1) promotes progression of tongue squamous cell carcinoma (TSCC) via activation of NF-κB signaling.
    Chen WC; Li QL; Pan Q; Zhang HY; Fu XY; Yao F; Wang JN; Yang AK
    J Exp Clin Cancer Res; 2019 Apr; 38(1):167. PubMed ID: 30995931
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.